首页> 美国政府科技报告 >Salmonella-Escherichia coli/Mammalian-Microsome Reverse Mutation Assay with a Confirmatory Assay with Dimethylamino ethylazide (DMAZ)
【24h】

Salmonella-Escherichia coli/Mammalian-Microsome Reverse Mutation Assay with a Confirmatory Assay with Dimethylamino ethylazide (DMAZ)

机译:沙门氏菌 - 大肠杆菌/哺乳动物 - 微粒体反向突变检测与二甲氨基乙酰叠氮(DmaZ)的确证分析

获取原文

摘要

Dimethylamino-2-2ethyl azide (DMAZ, 99.3% pure) was tested for mutagenic potentials with Salmonella typhimurium strains, TA 98, TA 100, TA 1535, TA 1537 and Escherichia coli strain WP2 uvrA by plate incorporation method according to OECD TG 471 in compliance with Good Laboratory Practice. The doses tested with Salmonella tester strains and Escherichia coli up to 5000 micrograms/plate both in the presence and absence of S9 mix. The results showed that DMAZ produced positive response in the TA 100 and TA 1537 , both with and without metabolic activation. No positive response was observed with any of the remaining tester strains with and without activation. The confirmatory assay showed similar results with tester strains with and without activation.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号